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Charles R. J. C. Newton1,3,4 and Amina Abubakar1,3,4,5

Abstract
Background: In sub-Saharan Africa, common mental disorders (CMDs) like depression and anxiety are underinvestigated amongst young people living with HIV (YLWH). To address the gap, in Kenya we: a) determined the
prevalence of CMDs among YLWH compared to their uninfected peers; b) investigated HIV status as an
independent predictor of CMDs in young people; c) investigated CMDs risk and protective indicators with more
focus on YLWH.
Methods: Between November 2018 and September 2019, 819 young people aged 18–24 years (407 HIV-infected)
were recruited from two Counties on the Kenyan coast. Locally adapted pre-existing mental health measures,
Patient Health Questionnaire (9-item) and Generalized Anxiety Disorder scale (7-item), were administered among
other questionnaires via audio computer-assisted self-interview. Logistic regression was used to determine the
correlates of CMDs.
Results: Prevalence of CMDs was significantly elevated among YLWH compared to their uninfected peers i.e. 29%
vs. 12%; p < 0.001 for depressive symptoms, 19% vs. 8%; p < 0.001 for anxiety symptoms, and 16% vs. 5%; p < 0.001
for comorbid depressive and anxiety symptoms. HIV status independently predicted depressive symptoms and its
co-occurrence with anxiety symptoms. Among YLWH, negative life events, higher perceived HIV-related stigma and
low adherence to antiretroviral therapy were the risk indicators for elevated CMDs. Among HIV-uninfected youths,
death of both parents was a risk indicator for elevated depressive symptoms. Protective indicators against CMDs
among youths with and without HIV included higher social support and health-related quality of life.
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Conclusion: At the Kenyan coast, YLWH have significantly higher burden of CMDs compared to their uninfected
peers. Being HIV-positive as a youth in this setting is predictive of more depressive symptoms and its comorbidity
with anxiety symptoms. YLWH at high risk of CMDs in coastal Kenya can benefit from early detection, referral and
treatment if routine screening for CMDs is integrated in their care package. The mental wellbeing of bereaving HIVunaffected youths could be improved through continued support to help them come to terms with their loss. At
the community level, programmes strengthening the social capital or improving the overall quality of life of youths
with or without HIV may be beneficial to their mental health.
Keywords: Common mental disorders, HIV infections, Young people, Prevalence, Correlates

Background
Currently, young people below the age of 25 years constitute 42% of the world’s population, with the vast majority of them residing in resource-limited settings [1].
These young people are disproportionately affected by
the HIV/AIDS epidemic. Globally, an estimated 3.9 million young people aged 15–24 years are living with HIV
[2], more than three-quarters of them residing in subSaharan Africa [3]. Between 2005 and 2016, the number
of young people living with HIV (YLWH) rose by 30%
globally [4]. This rising trend could result from the improved survival of YLWH on combined anti-retroviral
therapy (cART), where perinatally HIV-infected children
are reaching adolescence and young adulthood in large
numbers [5, 6]. New HIV infections may also be contributing to the rising number of YLWH. It is reported that
nearly half of new HIV infections are occurring in young
people [7]. In Kenya, for instance, young people (15–24
years old) were estimated to contribute over half of new
adult HIV infections in the year 2015 [8].
With increased survival, many more YLWH will develop
mental health problems [5]. This may stem from normative challenges coping with developmental changes
occurring in adolescence across the physical, cognitive,
emotional and social domains; as well as challenges associated with transitioning from adolescence to adulthood
and school- or work-related stressors. However, for
YLWH, normative challenges may be complicated by
HIV-specific challenges such as adjustment difficulty to
living with a chronic illness as a young person, the challenge of adhering to lifetime cART medication and coping
with prospective HIV-related stigma, which may lead to
additional psychological distress [9–11].
In the last decade, comorbidity of HIV/AIDS and common mental disorders (CMDs), mainly depression and
anxiety, has been well described among adults living
with HIV, including those from sub-Saharan Africa
where HIV burden is high [12, 13]. In contrast, among
YLWH, especially those from sub-Saharan Africa, there
is limited understanding of this comorbidity [14, 15]. A
systematic review of the literature, including 38 studies
mostly from Europe and North America, reports a

prevalence of CMDs of over 30% among YLWH [5].
Emerging studies from sub-Saharan Africa also report a
high prevalence of CMDs among YLWH, ranging from
18 to 53% for depressive symptoms [16–18] and from 5
to 25% for anxiety disorders [18, 19].
Correlates of CMDs among YLWH are hard to delineate because few studies on this topic have been conducted thus far and the findings are inconsistent.
Generally, the investigated correlates include both risk
and protective indicators and can be categorized as
demographic, psychosocial, or HIV-related clinical factors. According to the review of studies mostly from
Europe and North America [5], older age and being female were the frequently reported demographic risk indicators for elevated CMDs among YLWH. This finding
is also emerging from studies conducted in sub-Saharan
Africa [14, 16, 20]. Even so, the male sex has been reported as a predictor of higher depressive scores in
YLWH by a study conducted in England [21]. HIVrelated stigma among YLWH appears an important psychosocial risk indicator for elevated CMDs from recent
African-based reports [14, 20, 22], a finding also observed elsewhere [23]. Other identified psychosocial risk
indicators for elevated CMDs among YLWH, but with
little or no consensus from past studies, include an experience of negative or stressful life events [24], poor adherence to cART [5, 20], HIV clinic inaccessibility [15]
and disclosure of HIV status [25]. Similarly, several HIVrelated clinical factors have been investigated as risk indicators for elevated CMDs among YLWH but with little
or no consensus. These include low cluster of
differentiation-4 cell count [23], presence of HIV opportunistic infections [20], cART regimen particularly efavirenz use [26], duration on cART [9] and its side effects
[22]. The role of HIV status (being positive or not) in increasing the risk for CMDS among YLWH also remains
unclear as studies report mixed findings [21, 27, 28].
The literature on protective indicators against CMDs
in YLWH is particularly scanty. The few published studies report individual-level factors such as better overall
health [22], nutritional status [26], and satisfaction with
physical appearance [25] as significantly lowering the
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risk of CMDs among YLWH. Psychosocial factors such
as higher social support [17, 22], self-efficacy [22] and
positive parenting [22] have been identified as protective
against CMDs among YLWH in Africa, but by a single
study or studies from the same country (South Africa).
We are not aware of published research, specifically
from other African countries, corroborating any of these
findings. It remains unclear whether better quality of life
may be protective against CMDs comorbid with HIV in
young people, but a significant inverse association has
been observed between quality of life and depressive
symptoms among adults living with HIV in the African setting and beyond [29, 30]. Of the HIV-related
factors, the absence of immunosuppression among
YLWH [25] has been reported as a protective indicator against CMDs.
In sub-Saharan Africa, investigations of the burden
and factors associated with CMDs among YLWH are
generally limited compared to similar research among
adults with HIV. Of the existing reports from this setting, very few have simultaneously investigated the burden of multiple CMDs in YLWH [24] or enrolled an
appropriate control group for comparison purposes [24,
28]. There are inconsistencies too across studies in terms
of reported correlates of CMDs among YLWH. More
insight on the contextual factors influencing the mental
health of YLWH in the African context is important to
inform evidence-based interventions. As an addition to
the limited and unclear body of knowledge, the present
study from the Kenyan coast was designed to: i) determine the prevalence of CMDs, specifically depressive
symptoms and generalized anxiety disorder symptoms,
among YLWH compared to their uninfected peers; ii)
investigate HIV status as an independent predictor of
CMDs in a sample of young people; iii) investigate
CMDs risk and protective indicators with more focus on
YLWH across demographic, psychosocial and also HIVrelated clinical factors. To the best of our knowledge,
this is the first study in Kenya comparing the burden of
CMDs between YLWH and their uninfected peers.

Methods
Study design and setting

This cross-sectional study was conducted at the Kenyan
Coast in Kilifi and Mombasa Counties, between November 2018 and September 2019. Kilifi County is mostly a
rural setting with an estimated population of 1.5 million
people [31]. The main economic activity in this County
is subsistence farming and fishing [32]. HIV prevalence
among individuals aged 15 years and above in Kilifi
County is estimated at 4.5%, slightly lower than the national average prevalence of 6% [33]. Mombasa County
borders Kilifi County to the north. It is an urban County
where one of the three major cities of Kenya (Mombasa)
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is located, and has an estimated population of 1.2 million
people [31]. Because of urbanicity, the County consists of
a mix of local and immigrant communities from other
parts of Kenya. The main economic activity in this County
is tourism, which contributes about 68% of the employment wage [34]. HIV prevalence among individuals aged
15 years and above in this County is estimated at 7.5%, 1.2
times higher than the national prevalence [33].
Study participants and recruitment
Young people living with HIV

YLWH were recruited from 20 public HIV specialized
clinics in Kilifi (n = 13) and Mombasa Counties (n = 7)
through consecutive sampling. These clinics were selected carefully to ensure regional representativeness
and a fair pool of urban/peri-urban clinics and remote/
rural clinics. As inclusion criteria, individuals had to be
18–24 years old, with a confirmed HIV-positive status,
on cART and provide informed consent for their participation. Pregnancy is a time of increased vulnerability for
developing depression and anxiety and the risk may particularly be elevated if the pregnancy is unwanted or unplanned [35]. Therefore, we excluded females whose
medical records indicated they were pregnant or those who
self-reported being pregnant upon enquiry to minimize the
potential for overestimating the prevalence of our outcomes
of interest (depressive and anxiety symptoms).
In all facilities, we used existing records to identify all
potential participants assisted by peer educators or
health care providers. An effort was made to contact all
those who had available working contact details (in an
alphabetic order) to invite them to study briefs on a day
coinciding with the structured monthly teen support
group meetings. Those who could not be reached via the
provided mobile contacts or had no contact details were
traced during their next scheduled clinic appointment
dates. Study introductions were done on one or multiple
occasions (depending on facility volume). Recruitments
and bookings for assessment were performed on those
who consented after being taken through the study in
details by research assistants present at the time of the
meeting. Throughout the data collection period, recruitment was conducted and completed in one facility before moving to the next facility. We stopped recruiting
at a facility when no more new, eligible and consenting
study participants could be identified.
Young people without HIV

Young people without HIV, hereafter referred to as
community controls, were recruited mainly through
consecutive sampling following study advertisements on
posters and flyers. Recruitment was restricted to communities adjacent to the facility from where we recruited
YLWH. To be included in the study, individuals had to
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be 18–24 years old, residents of Kilifi or Mombasa
Counties and provide consent for participation, including willingness to self-test for HIV using an oral selftesting kit (OraQuick) for a confirmation of HIV negative status. Like YLWH, we excluded females who selfreported being pregnant upon enquiry.
In Kilifi County, other than the use of posters and
flyers to recruit participants, we also recruited some participants through the Kilifi Health and Demographic
Surveillance System (KHDSS) [32]. In Mombasa County,
recruitment was solely based on the informational materials distributed in the communities as currently there is
no existing surveillance system. Under KHDSS recruitment, potential participants 18–24 years old were randomly identified from the existing database and
followed-up at their homesteads by our research assistants for potential recruitment. The study information
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sheet was given or explained to those who showed interest of participation (in English or the national language
– Kiswahili, as preferred). Consenting and booking for
assessments was done on site to those willing to participate. On the day of assessment, re-affirming consent was
done as the first thing before any assessment began by a
different research assistant. Figure 1 details the recruitment process.
Sample size calculations

For prevalence estimates, the sample size was calculated
using a previously reported significant difference in the
prevalence estimate of depressive symptoms between
those living with HIV and community controls [36]. A
total sample of at least 718 individuals was required to
detect a difference in CMDs between YLWH and community controls at 80% power and 5% level of statistical

Fig. 1 Participant recruitment flowchart. YLWH – Young People Living With HIV/AIDS. KHDSS - Kilifi Health and Demographic Surveillance System.
‡
Due to a technical error on the windows tablet data capture platform, and participants could not be reached on contact details provided for reassessment. # HIV testing was the last step of community control assessments, and these participants declined to be tested even though they
initially consented
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significance. A sample of > 800 participants was considered sufficient to allow for missing data, non-contact, or
other factors that tend to reduce the final sample size. A
one-group sample (n = 400) from the above sample computation was > 90% powered to carry out a logistic regression analysis of the correlates of CMDs based on
previously reported effect sizes from a study conducted
in a similar setting [37].
Measures

Study instruments that do not ask about sensitive personal information were programmed on android tablets
using Research Electronic Data Capture (REDCap) platform [38] for face-to-face interviewer administration.
Study instruments asking about sensitive information
were completed using Audio Computer-Assisted Self
Interview (ACASI) on Windows tablets. In ACASI, participants privately listened to pre-recorded survey questions using headphones attached to a Windows tablet.
ACASI is preferred for responding to interview questions as it improves privacy, confidentiality and reduces
social desirability bias [39].
Interviewer-administered measures via android tablets

To administer the following tablet-based questionnaires,
research assistants received a week-long training from
the first author (MKN). The training was on study research methods, ethical research principles involving
humans as participants, and good interviewing skills
(with role plays).
Sociodemographic and asset index forms. The sociodemographic form captured participant’s age, sex, marital
status, educational level, employment status, the living
status of parents and whom they currently lived with.
The asset index form gathered information about individual or family ownership of disposable items as a
proxy indicator of socioeconomic status.
The 24-item Social Provisions Scale [40] was used to
tap perceived social support. This scale is rated on a 4point Likert scale with anchors of “1” (strongly disagree)
and “4” (strongly agree). Item scores are summated to
derive a total score ranging between 24 to 96; higher
scores indicating better perceived social support. In the
present study, the internal consistency alpha for this
scale was good, 0.84 (95% CI 0.82, 0.86).
The RAND 36-Item Self-report form [41] was used to
assess health-related quality of life. This scale assesses
health concepts in the domains of: physical functioning,
role limitations due to physical health or emotional
problems, social functioning, emotional wellbeing, energy/fatigue, pain and general health perceptions. According to the scoring method [41], items are scored on
varying Likert-type scales per domain, then summed and
averaged. Higher scores (as percentages) define a more
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favourable state of health. We have previously used this
scale in our setting with excellent reliability [29]. In the
present study, the internal consistency alpha for this
scale was excellent, 0.93 (95% CI 0.92, 0.94).
HIV-related health history and clinical records. For
YLWH only, HIV-specific questions were asked related
to the presence of any current chronic illness, opportunistic infection or cART side effects (as informed by their
clinician), disclosure of HIV status, clinic accessibility
and their satisfaction with the level of care they currently
received. Data regarding World Health Organization
(WHO) HIV clinical staging, recent body mass index,
current cART regimen and overall duration on cART
were extracted from medical records and health passports of participating YLWH and uploaded on the tablet’s electronic data capture platform. We also collected
blood samples from YLWH for definitive viral load
testing.
Measures administered via audio computer-assisted selfinterview (ACASI)

Participants first received a tutorial on how to use the
Windows tablet in answering questions. They had an option of choosing English or Kiswahili as their preferred
language for answering the questions. An option of “I do
not want to answer the question” was also provided inline with respecting a client’s right of not responding to
questions they do not wish to. There was also an
“assisted” version in Kiswahili language for individuals
unable (uncomfortable) to respond on their own due to
e.g. illiteracy. For such cases (n = 19), a trained research
assistant sat with the participant throughout the survey
to explain, clarify or translate into local language any
word, phrase or sentence as needed. In anticipation of
dealing with less literate participants, research assistants
were coached (with role plays) on how to help participants comprehend questions and giving them time and
space to respond on their own. The assistants were also
required to make their role clear before the start of an
interview session. Participants were informed about our
standby study counsellor for debriefing if they experienced distress as a result of completing the survey
questions.
Mental health measures. The 9-item Patient Health
Questionnaire (PHQ-9) [42] and the 7-item Generalized
Anxiety Disorder scale (GAD-7) [43] were used to measure depressive and anxiety symptoms, respectively. Items
in these measures are rated on a 4-point Likert scale of
“0” (not at all) to “3” (nearly every day). Item scores are
summated to derive a total score that ranges from 0 to
27 for PHQ-9, and 0–21 for GAD-7. For PHQ-9, total
scores of 5–9, 10–14, 15–27 indicate mild, moderate,
and severe depressive symptoms, respectively. GAD-7
scores of 5–9, 10–14, and 15–21 indicate mild,
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moderate, and severe anxiety symptoms, respectively.
The recommended optimal cut-off score of ≥10 for both
PHQ-9 and GAD-7 [42, 43], also applicable in subSaharan Africa [44, 45], was used to define positive
screen for depressive and anxiety symptoms. PHQ-9 and
GAD-7 have locally been validated, showing good psychometric properties [46, 47]. In the present study, the
internal consistency alphas for PHQ-9 and GAD-7 were
all good, 0.83 (95% CI 0.81, 0.86), and 0.86 (95% CI 0.84,
0.88), respectively.
Negative life events score index. A 15-item scale of
negative life events was assembled adapting items from
the life events questionnaire [48] and from a previous
study [49]. Items covered individual-related negative
events (e.g. severe illness, lack of basic needs, financial
worries), negative events in the domains of school (e.g.
quitting school), relationships and love (e.g. infidelity,
break-ups), family, close friends and relatives (e.g. bereavement), crime and legal matters (e.g. if ever been
robbed or jailed). Respondents were asked to indicate
whether they experienced such negative events in the past
1 year on a dichotomous scale (yes/no). A total score was
generated to reflect the total number of life events reported. In the present study, this scale had an acceptable
internal consistency alpha, 0.74 (95% CI 0.71, 0.77).
The brief 12-item HIV stigma scale [50] was used to
assess participants perceived HIV-related stigma rated
on a 4-point Likert scale as “1” (strongly disagree), “2”
(disagree) “3” (agree) and “4” (strongly agree). Item
scores are summated to derive a total score that ranges
between 12 and 48, higher scores indicating a greater
level of perceived stigma. We have previously used this
scale in our setting with good reliability alpha [51]. In
the present study, this scale had good internal
consistency alpha, 0.81 (95% CI 0.78, 0.84).
The 4-item Morisky, Green and Levine Medication Adherence Scale (MGLS) [52] was used as a self-report
measure of cART adherence. The MGLS has a total
score ranging from 0 to 4 and based on this score, there
are 3 levels of medication adherence: high (a score of 0),
medium (scores of 1 or 2), and low adherence (scores
≥3). In the original validation of MGLS, its reliability
was acceptable and concurrent and predictive validities
were established [52]. In this study, MGLS had acceptable internal consistency alpha, 0.69 (95% CI 0.62, 0.76).
Cross-cultural adaptation of study measures

In this study, all questionnaires not previously adapted
to the local language of Kiswahili (the social provisions
scale, the negative life events index score and the MGLS)
underwent the recommended cross-cultural validation
process [53] and in line with international guidelines in
health research (https://www.who.int/substance_abuse/
research_tools/translation/en/). These measures were
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independently translated from English to Kiswahili by
two staff members fluent in both languages, then backtranslations into English were done by another independent pair of translators. A group of HIV researchers
in the department (natives of Kenya, knowledgeable
about the Kenyan culture, bilingual and fluent in English
and Kiswahili) and the translators then held a
harmonization meeting to review the content, conceptual and cultural appropriateness of the questions to the
targeted sample. Discrepancies in the translations were
resolved by consensus. No issues arose during the tool
pretesting stage to necessitate item modification, and
these measures were therefore regarded as the final Kiswahili versions.
Statistical analysis

Data were analysed for 812 participants. All analyses
were conducted in STATA version 15.0 (StataCorp LP,
College Station, Texas, United States of America [USA]).
The choice of variable reference category in the analysis
of this work was informed by variable categorization in
previous research on this topic.
Summary of data by participant group

Descriptive statistics were used to summarize sample
characteristics by HIV status. Chi-square test and independent Student’s t-test were used to compare group
differences on categorical and continuous independent
variables, respectively.
Analysis of prevalence data

Proportions as percentages were used to estimate the
prevalence of CMDs (depressive symptoms, anxiety
symptoms, and their comorbidity) among YLWH and
their uninfected peers. A positive screen for any CMD
was defined using the recommended cut-off score of
≥10. Chi-square test and two-sample test of proportions
(prtest) were used to compare group differences on ordinal and binary outcome variables, respectively.
Analysis of risk and protective indicators for CMDs

To investigate HIV status as an independent predictor
of CMDs, we used logistic regression analyses adjusting
for contextual variables that accounted for differences
in mental health (sex, education level, employment status, parental loss and negative life events). Investigation
of correlates of CMDs applied logistic regression
models to assess univariate associations between the
binary outcome variables (depressive symptoms, anxiety
symptoms and their comorbidity) and exposure variables
(demographic, psychosocial, and HIV-related clinical factors). Exposure variables having a p-value < 0.15 in the
univariate analysis were entered into the multivariable logistic regression models using forward selection. All
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multivariable models included age and sex as a priori factors found to be associated with CMDs from the literature. In all the models, collinearity diagnostics were
performed using STATA’s ‘collin’ syntax and based on the
variance inflation factor, no multicollinearity problems
were identified. For all tests of hypothesis, a two-tailed pvalue of < 0.05 was considered statistically significant, with
a confidence interval of 95% used to report on the precision of the reported estimates. The overall fit of the final
models was assessed by Hosmer and Lemeshow goodness
of fit test, where p-value > 0.05 was regarded a good fit.
Data for YLWH and community controls were separately
analysed.

Results
Overall sample characteristics

Table 1 shows results from a descriptive analysis of participant demographic and psychosocial characteristics
disaggregated by HIV status. Statistical group differences
are also presented. In summary, the mean age of the
participants was 20.9 (SD = 2.1) years, with 50.7% being
females. There was a near equal number of participants
from both Counties. A majority (82.7%) of these young
people were never married. Only 1.5% of them had no
formal education. Most of the study participants were either students (37.3%) or unemployed (47.8%). About
18% of these young people reported that both their parents had died (mostly YLWH, n = 132 than community
controls, n = 13). Over three-quarters (88.7%) of the
study participants lived with immediate family or with a
relative at the time of data collection. Over a quarter
(31.5%) reported having experienced 6 or more negatives
events in their life in the past 1 year.
Significant sociodemographic differences were observed between YLWH and their uninfected peers in
terms of sex, marital status and education level, all
p < 0.01 (Table 1).
HIV-related clinical and psychosocial characteristics of
YLWH

Table 2 shows results from a descriptive analysis of
HIV-related clinical and psychosocial characteristics of
YLWH. In summary, their mean body mass index was
within the normal range (mean [SD] = 20.6 [3.6]). Most
of these YLWH were on cART for over 5 years (57.9%),
largely first-line regimen (81.3%) and were highly adherent based on self-report (62.6%). Over half were in stage
1 of WHO clinical staging of HIV (61.5%) and had viral
load ≤1000 copies/mL (69.0%). More than threequarters of YLWH were generally satisfied with the
current level of care they were receiving (94.3%), had
disclosed their HIV status (93.8%), reported no current
comorbid chronic illness (98.3%), reported absence of
any current opportunistic infection (93.8%) or
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medication-related side-effects (73.1%). A quarter of
YLWH (25.1%) reported their present HIV point of care
as not easily accessible.
Prevalence of common mental disorders

Table 3 presents prevalence estimates for CMDs
among YLWH compared to their HIV-uninfected
peers. The prevalence of CMDs was significantly
higher among YLWH compared to community controls in terms of severity levels and positive screening using the recommended cut-off score of ≥10.
The prevalence of a positive screen for depressive
symptoms was 28.8% among YLWH compared to
12.1% in community controls (p < 0.001). The prevalence of a positive screen for anxiety symptoms was
19.0% among YLWH compared to 7.6% in community controls (p < 0.001). The prevalence of comorbid
positive screen for depressive and anxiety symptoms
among YLWH compared to community controls was
16.0% vs. 4.7% (p < 0.001).
Association between HIV status and common mental
disorders

Table 4 presents results from logistic regression analyses examining the association between HIV status
(exposure) and CMDs (outcome). In univariate logistic regression analysis, being HIV positive was
significantly associated with higher odds of (a positive screen for) depressive symptoms, anxiety symptoms and their co-occurrence (Table 4). Adjusting
for sex, education level, employment status, parental loss and negative life events in the multivariable
analysis (Table 4), being HIV positive remained significantly associated with higher odds of depressive
symptoms (aOR 1.77 95% CI 1.13, 2.79) and cooccurrence of depressive and anxiety symptoms
(aOR 3.88 95% CI 2.28, 6.61), but not anxiety
symptoms alone (aOR 1.51 95% CI 0.88, 2.58).
Repeating this analysis by including all variables associated with CMDs at p < 0.15 in the multivariable
logistic analysis as covariates, age and sex fixed (data
not shown), findings were similar. Being HIV positive
was significantly associated with higher odds of depressive symptoms, its co-occurrence with anxiety
symptoms, but not anxiety symptoms alone. Additionally, experiencing 6 or more negative life events was
significantly associated with higher odds of depressive
symptoms (aOR 2.82 95% CI 1.87, 4.26), anxiety
symptoms (aOR 2.67 95% CI 1.64, 4.34), and their
co-occurrence (aOR 2.35 95% CI 1.36, 4.06). Death of
both parents was significantly associated with nearly
2-times higher odds of anxiety symptoms (aOR 1.91
95% CI 1.05, 3.49). Being female was also significantly
associated with higher odds of co-occurrence of
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Table 1 Sociodemographic and psychosocial characteristics of young people from the Kenyan coast by HIV status, n = 812
Characteristic

Total
sample
n = 812

HIV status
HIV uninfected youths, n = 406

HIV infected youths, n = 406

Kilifi

403 (49.6)

200 (49.3)

203 (50.0)

Mombasa

409 (50.4)

206 (50.7)

203 (50.0)

20.9 (2.1)

21.0 (1.9)

20.8 (2.2)

Male

400 (49.3)

224 (55.2)

176 (43.4)

Female

412 (50.7)

182 (44.8)

230 (56.7)

Never married

670 (82.7)

358 (88.6)

312 (76.9)

Separated/Divorced/Widowed

32 (4.0)

8 (2.0)

24 (5.9)

Married/cohabiting

108 (13.3)

38 (9.4)

70 (17.2)

Tertiary

193 (23.8)

130 (32.0)

63 (15.5)

Secondary

354 (43.6)

179 (44.1)

175 (43.1)

Primary

253 (31.2)

93 (22.9)

160 (39.4)

None

12 (1.5)

4 (1.0)

8 (2.0)

p-value#

Study sites

Age -years, mean (SD)

0.83

0.13

Sex
< 0.01

Marital status, OM = 2
< 0.01

Education level
< 0.01†

Employment
Formally employed

27 (3.3)

11 (2.7)

16 (3.9)

Self-employed

94 (11.6)

52 (12.8)

42 (10.3)

Student

303 (37.3)

162 (39.9)

141 (34.7)

Unemployed

388 (47.8)

181 (44.6)

207 (51.0)

Both parents alive

429 (52.8)

308 (75.9)

121 (29.8)

One parent alive

238 (29.3)

85 (20.9)

153 (37.7)

Both parents died

145 (17.9)

13 (3.2)

132 (32.5)

Family/Relative

720 (88.7)

359 (88.4)

361 (88.9)

Friend/non-relative

17 (2.1)

8 (2.0)

9 (2.2)

Alone

75 (9.2)

39 (9.6)

36 (8.9)

None

80 (9.9)

51 (12.6)

29 (7.1)

1–5 events

476 (58.6)

255 (62.8)

221 (54.4)

6+ events

256 (31.5)

100 (24.6)

156 (38.4)

0.16

Parental loss
< 0.01

Living arrangement
0.91

Negative life events

Asset index score – mean (SD)

2.4 (1.6)

2.6 (1.6)

2.2 (1.6)

Social support score b – mean (SD)

71.6 (8.7)

72.1 (7.8)

71.1 (9.5)

Quality of life score – mean (SD)

78.8 (15.3)

82.7 (12.0)

74.8 (17.2)

a

c

< 0.01

< 0.01
0.09
< 0.01

All numbers are reported as frequencies with percentages unless otherwise specified
# p-values are for the difference between HIV infected and uninfected youths by sample characteristic
†
based on Fisher’s exact test, SD standard deviation, OM observation with missing value, a – score range = 0 to 7, higher scores indicate better socioeconomic
status, b – score range = 24 to 96, higher scores indicate more perceived social support, c – higher scores indicate better state of perceived health

depressive and anxiety symptoms (aOR 1.89 95% CI
1.08, 3.33). Higher social support and health-related
quality of life were significantly associated with lower
odds of a positive screen for CMDs.

Risk and protective indicators of common mental
disorders in YLWH

Table 5 presents results from logistic regression analyses
examining the correlates (both risk and protective
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Table 2 HIV-related clinical and psychosocial characteristics of
YLWH from the Kenyan coast, n = 406

Table 2 HIV-related clinical and psychosocial characteristics of
YLWH from the Kenyan coast, n = 406 (Continued)

Characteristic

Mean/Frequency

SD/percent

Characteristic

Recent Body Mass
Index – kg/m2, mean, SD

20.6

3.6

Satisfaction with current care

Any current chronic illness
No

399

98.3

Yes †

7

1.7

330

81.3

76

18.7

≤ 1000 copies/mL

280

69.0

> 1000 copies/mL

126

31.0

Stage 1

249

61.5

Stage 2

102

25.2

Stage 3

52

12.8

Stage 4

2

0.5

> 5 years

235

57.9

1–5 years

124

30.5

6-11 months

25

6.2

< 6 months

22

5.4

No

381

93.8

Yes

25

6.2

296

73.1

cART regimen
First line
Second line

1

Mean/Frequency

SD/percent

Satisfied

383

94.3

Neutral

16

3.9

Not satisfied

7

1.7

– score range = 12 to 48, higher scores indicate increased perceived HIVrelated stigma, † one or more chronic illness in addition to HIV, OM
observation with missing value, WHO world health organization, cART
combination antiretroviral therapy, 1- all participants were initially started on
1st line cART but had changed to 2nd line cART at the time of data collection
a

Viral load

WHO clinical stage, OM = 1

Duration on cART

Any current opportunistic
infection

Any cART side effects, OM = 1
No

109

26.9

26.1

7.5

High adherence

254

62.6

Medium adherence

117

28.8

Low adherence

35

8.6

Yes

381

93.8

No

25

6.2

Easily accessible
(Less than 30 min)

129

31.8

Somehow accessible
(30 min to 1 h)

175

43.1

Not accessible (> 1 h)

102

25.1

Yes
Perceived HIV-stigma
score a – mean, SD
Medication (cART)
adherence

HIV status disclosure

Clinic accessibility

indicators) of CMDs among YLWH. Under univariate
analysis, factors that were significantly associated with
higher odds of (a positive screen for) depressive symptoms among YLWH included: increasing age, being female, having primary education (relative to secondary
education), being unemployed, death of both parents,
experiencing 6 or more negative life events (in the past 1
year), low and medium adherence to cART, perceived
HIV-related stigma and presence of cART side effects
(p < 0.05; Table 5). Higher social support and healthrelated quality of life were significantly associated with
lower odds of depressive symptoms. High viral load (>
1000 copies/mL) and being on cART for less than 6
months were associated with a positive screen for depressive symptoms at p-value < 0.15 and were all included in multivariable logistic regression analysis. In
the multivariable model, with age and sex fixed, factors
significantly associated with higher odds of depressive
symptoms among YLWH were negative life events (6 or
more) and perceived HIV-related stigma (Table 5).
Higher social support and health-related quality of life
were significantly associated with lower odds of depressive symptoms (Table 5).
Factors that were significantly associated with higher
odds of (a positive screen for) anxiety symptoms among
YLWH in the univariate analysis included: being female,
having primary education, being unemployed, living
alone, death of both parents, experiencing 6 or more
negative life events, low and medium adherence to
cART, and perceived HIV-related stigma (p < 0.05; Table
5). Having more assets (a proxy for better socioeconomic
status), higher social support and health-related quality
of life were significantly associated with lower odds of
anxiety symptoms. Increasing age and body mass index
were associated with a positive screen for anxiety symptoms at p-value < 0.15 and were all included in multivariable analysis. Fixing age and sex as constant in the
multivariable models (Table 5), low adherence to cART
and perceived HIV-related stigma were significantly associated with higher odds of anxiety symptoms among
YLWH. Higher social support and health-related quality
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Table 3 Prevalence of common mental disorders in YLWH versus their uninfected peers from the Kenyan coast
HIV uninfected youths, n = 406

HIV infected youths, n = 406

Frequency

Prevalence (95% CI)

Frequency

Prevalence (95% CI)

p-value

Severity of depressive symptoms
Mild

86

21.2 (17.5, 25.4)

130

32.0 (27.6, 36.7)

Moderate

34

8.4 (6.0, 11.5)

78

19.2 (15.7, 23.4)

< 0.001†

Moderately severe

12

3.0 (1.7, 5.1)

30

7.4 (5.2, 10.4)

Severe

3

0.7 (0.2, 2.3)

9

2.2 (1.2, 4.2)

49

12.1 (9.2, 15.6)

117

28.8 (24.6, 33.4)

< 0.001#

Mild

98

24.1 (20.2, 28.6)

138

34.0 (29.5, 38.8)

< 0.001

Moderate

20

4.9 (3.2, 7.5)

54

13.3 (10.3, 17.0)

Severe

11

2.7 (1.5, 4.8)

23

5.7 (3.8, 8.4)

7.6 (5.4, 10.7)

77

19.0 (15.4, 23.1)

< 0.001#

65

16.0 (12.7, 19.9)

< 0.001#

Positive depression screen (cut-off score ≥ 10)
Yes
Severity of GAD symptoms

Positive GAD screen (cut-off score ≥ 10)
Yes

31

Positive screen for comorbid depressive and GAD symptoms
Yes

19

4.7 (3.0, 7.2)

95% CI 95% confidence interval, GAD Generalized anxiety disorder
†
based on Fisher’s exact test
#
based on prtest, a two-sample test of differences in proportion using defined binary groups

of life remained significantly associated with lower odds
of anxiety symptoms (Table 5).
Factors that were significantly associated with higher
odds of (a positive screen for) comorbid depressive and
anxiety symptoms among YLWH in the univariate analysis included: increasing age, being female, having primary education, living alone, death of both parents,
experiencing 6 or more negative life events, low and
medium adherence to cART, and perceived HIV-related
stigma (p < 0.05; Table 5). Having more assets, higher social support and health-related quality of life were significantly associated with lower odds of comorbid
depressive and anxiety symptoms. Fixing age and sex as
constant in the multivariable logistic models (Table 5),
low adherence to cART and perceived HIV-related
stigma were significantly associated with higher odds of
comorbid depressive and anxiety symptoms among
YLWH. Higher social support and health-related quality
of life remained significantly associated with lower odds
of comorbid depressive and anxiety symptoms (Table 5).
Risk and protective indicators of common mental
disorders in HIV-uninfected community controls: a
snapshot summary

This work mostly focused on YLWH. As such, data collected from HIV-uninfected young people was not as robust as that collected from YLWH to comprehensively
look at factors associated with CMDs. For instance, data
about community experiences or health aspects of HIVuninfected peers were not collected. Here, we only

provide a snapshot summary of the correlates of CMDs
among community controls using the available data specifically focusing on depressive symptoms whose prevalence was relatively high in this sample (> 10%).
Under multivariable analysis (detailed data not shown),
the death of both parents (aOR 4.42 95% CI 1.15, 17.02)
was significantly associated with higher odds of (a positive screen for) depressive symptoms among community
controls. Higher social support (aOR 0.93 95% CI 0.88,
0.98) and health-related quality of life (aOR 0.92 95% CI
0.90, 0.95) were significantly associated with lower odds
of depressive symptoms.

Discussion
This study is among the few emerging reports from
sub-Saharan Africa investigating CMDs, specifically
depressive and anxiety symptoms, in YLWH compared to their HIV-uninfected peers. In summary, we
report significantly higher prevalence of CMDs in
YLWH compared to their uninfected peers. We found
HIV status an independent predictor of depressive
symptoms and its comorbidity with anxiety symptoms. Six or more negative life events (in the past 1
year) and perceived HIV-related stigma were significant risk indicators for elevated depressive symptoms
in YLWH. Low medication adherence and perceived
HIV-related stigma were significant risk indicators for
elevated anxiety symptoms and its comorbidity with
depressive symptoms in YLWH. Higher social support
and health-related quality of life were consistently
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Table 4 Association between HIV status and common mental disorders among young people from Kenyan coast
a

Positive screen for depressive
symptoms

Positive screen for GAD symptoms

Positive CMD comorbidity

Crude analysis
OR (95% CI)

Adjusted
analysisb
aOR (95% CI)

Crude analysis
OR (95% CI)

Adjusted
analysisb
aOR (95% CI)

Crude analysis
OR (95% CI)

Adjusted
analysisb
aOR (95% CI)

Negative

Ref

Ref

Ref

Ref

Ref

Ref

Positive

2.95** (2.04, 4.26)

1.77* (1.13, 2.79)

2.83** (1.82, 4.41)

1.51 (0.88, 2.58

3.88** (2.28, 6.61)

2.07* (1.11, 3.88)

Covariate

HIV status

Sex
Male

Ref

Ref

Ref

Female

1.41 (0.95, 2.09)

1.70* (1.06, 2.72)

2.16* (1.26, 3.70)

Secondary

Ref

Ref

Ref

Tertiary

1.16 (0.68, 1.97)

1.56 (0.84, 2.91)

1.77 (0.88, 3.56)

Primary

1.77* (1.13, 2.76)

1.67 (0.98, 2.83)

2.12* (1.17, 3.84)

None

2.20 (0.52, 9.27)

2.33 (0.49, 11.04)

0.78 (0.08, 7.31)

Education

Employment
Student

Ref

Ref

Ref

Self-employed

0.68 (0.33, 1.38)

1.24 (0.55, 2.79)

0.62 (0.23, 1.67)

Formally employed

1.10 (0.40, 3.00)

1.95 (0.65, 5.80)

1.59 (0.50, 5.13)

Unemployed

1.14 (0.73, 1.80)

1.45 (0.83, 2.54)

1.12 (0.61, 2.06)

Both parents alive

Ref

Ref

Ref

One parent alive

1.32 (0.83, 2.09)

1.83* (1.06, 3.15)

1.83 (0.99, 3.39)

Both parents died

1.80* (1.06, 3.06)

2.40* (1.30, 4.44)

2.26* (1.15, 4.45)

Nonec

0.20* (0.05, 0.87)

1.00

1.00

1–5 events

Ref

Ref

Ref

6+ events

4.26** (2.89, 6.27)

4.00** (2.54, 6.31)

3.80** (2.28, 6.35)

Parental loss

Negative life events

n of the final model

812

732

732

Hosmer-Lemeshow
Test

X2 = 218.73; p = 0.26

X2 = 168.42; p = 0.48

X2 = 170.68; p = 0.43

Variance explained

17.1%

15.0%

16.7%

GAD Generalized anxiety disorder, CMD Common mental disorder, OR odds ratio, aOR adjusted odds ratio, Ref reference group
* - p value< 0.05, ** - p value <0.001
a
- co-occurrence of positive screen for depressive and anxiety symptoms
b
− adjusted for sex, level of education, employment, death of parent(s) and negative life events (in the past 1 year)
c
− for this category, no participant screened positive for anxiety or comorbidity symptoms, hence predicted failure perfectly and consequently 80 observations
were not used

associated with lower depressive symptoms, anxiety
symptoms and their comorbidity in YLWH. The
death of both parents was a significant risk indicator
for the relatively high depressive symptoms observed
among community controls. Like in YLWH, higher
social support and health-related quality of life were
significantly associated with lower depressive symptoms among community controls.
Our finding that CMDs are significantly higher in
YLWH than their uninfected peers is similar to findings
from a study conducted in Tanzania [28]. Among

YLWH, our prevalence estimate of CMDs compares to
that reported in Rwanda [54] and Tanzania [28]. It is
higher than previously reported estimates from Malawi
[25] and South Africa [18], but lower than estimates reported from Zimbabwe [55] and USA [5] . The differences in prevalence estimates could be due to the
differences in the study setting and measures used.
Compared to the prevalence of depressive symptoms
among the general adult population living with HIV
from our setting [51], we report a higher estimate among
YLWH.

1.61 (0.52, 4.99)

1.97*** (1.21, 3.22)

Formally employed

Unemployed

2.53*** (1.50, 4.26)
–

4.30*** (2.70, 6.84)

–

Asset index

6+ events

Ref

0.16* (0.02, 1.22)

Ref

1–5 events

0.81** (0.68, 0.95)

3.64*** (2.15, 6.18)

Ref

3.44*** (1.96, 6.05)

–

0.76*** (0.63, 0.92)

Ref
–

1.00
–

2.34** (1.12, 4.85)

1.86* (0.90, 3.86)

Ref

–

–

–

2.56** (1.19, 5.50)

0.73 (0.09, 5.93)

Ref

1.75* (0.95, 3.23)

2.43 (0.70, 8.40)

0.77 (0.24, 2.42)

Ref

1.17 (0.14, 10.06)

2.22** (1.21, 4.07)

1.74* (0.78, 3.89)

Ref

2.07** (1.16, 3.67)

Ref

1.14** (1.01, 1.29)

Univariate
analysis
OR (95% CI)

–

–

–

–

–

–

–

–

–

–

–

–

–

–

–

–

–

–

–

1.45 (0.73, 2.85)

Ref

1.06 (0.92, 1.23)

Multivariable
analysis
aOR (95% CI)

Positive CMD Comorbiditya

(2021) 21:90

Noneb

1.00

2.88*** (1.44, 5.78)

–

1.86** (1.07, 3.25)

Negative life events
0.26 (0.03, 2.02)

2.03* (1.01, 4.08)

–

1.41 (0.81, 2.44)

Both parents died

Ref

–

Ref

Both parents alive

–

–

–

–

–

One parent alive

Parental loss

2.32** (1.10, 4.88)

0.58 (0.07, 4.72)

Ref

–

–

–

–

–

–

–

–

1.41 (0.74, 2.66)

Ref

1.01 (0.88, 1.16)

Multivariable
analysis
aOR (95% CI)

–

–
–

–

–

Friend/non-relative

Alone

Psychosocial:

–

3.32* (1.03, 10.71)
2.32*** (1.28, 4.23)

–
–

–

Ref
0.99 (0.34, 2.85)

–

Family/Relative

Living arrangement

Ref

0.71 (0.29, 1.75)

Student

Self-employed

–

2.00 (0.38, 10.47)

–

2.03 (0.46, 8.84)

Employment

None

1.41 (0.66, 3.01)
1.87** (1.07, 3.27)

–
–

1.25 (0.65, 2.41)

1.87** (1.16, 3.01)

Tertiary

Ref

2.04*** (1.20, 3.48)

Ref

1.09* (0.97, 1.22)

Univariate
analysis
OR (95% CI)

–

1.08 (0.63, 1.84)

1.62** (1.04, 2.53)

Ref

Ref

1.02 (0.91, 1.15)

Multivariable
analysis
aOR (95% CI)

Ref

1.12** (1.02, 1.24)

Univariate
analysis
OR (95% CI)

Positive screen for GAD symptoms

Primary

Secondary

Education level

Demographic:

Female

Male

Sex

Age

A priori:

Covariate

Positive screen for depressive
symptoms

Table 5 Univariate and multivariable analysis of correlates of common mental disorders among YLWH from Kenyan coast
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0.95*** (0.93, 0.96)

6.32*** (2.97, 13.49)

1.44* (0.92, 2.27)

> 1000 copies/mL

X2 = 437.56; p-value = 0.08

X2 = 380.22; p-value = 0.73
0.78 (0.69, 0.81)

cvMean AUC (95% CI)

–

–

–

–

–

–

–

–

–

1.12*** (1.07, 1.16)

4.77*** (2.16, 10.51)

2.08** (1.15, 3.78)

Ref

0.95*** (0.93, 0.96)

0.92*** (0.89, 0.95)

Univariate
analysis
OR (95% CI)

0.81 (0.74, 0.86)

X2 = 402.55; p-value = 0.43

25.0%

406

–

–

–

–

–

–

–

–

–

1.07*** (1.02, 1.12)

2.49** (1.02, 6.06)

1.76 (0.88, 3.52)

Ref

0.96*** (0.94, 0.98)

0.94*** (0.91, 0.97)

Multivariable
analysis
aOR (95% CI)

Positive CMD Comorbiditya

(2021) 21:90

Only a priori variables (age, sex), as well as those with p-value < 0.15 in the univariate analysis or multivariable p < 0.05 are presented here
GAD Generalized anxiety disorder, CMD common mental disorder, OR odds ratio, aOR adjusted odds ratio, Ref reference group, cvMean AUC cross-validated mean area under the curve for the final multivariable model
* - p value< 0.15, ** - p value < 0.05, *** - p value < 0.01
a
- co-occurrence of positive screen for depressive and anxiety symptoms
b
− for this category, no participant screened positive for anxiety or comorbidity symptoms, hence in the univariate analysis it predicted failure perfectly

0.81 (0.77, 0.88)

26.2%

22.3%

Hosmer-Lemeshow test

406

–

Variance explained

–

–

–

–

406

–

1.75** (1.09, 2.78)

–

–

–

–

–

–

–

1.09*** (1.04, 1.14)

2.97** (1.27, 6.95)

1.58 (0.82, 3.04)

Ref

0.96*** (0.94, 0.97)

0.95*** (0.92, 0.98)

Multivariable
analysis
aOR (95% CI)

n for the final model

Yes

No

–

–

–

< 6 months

–

–

6-11 months

–

–

–

–
–

–

1.05* (0.99, 1.12)

–

–

Ref

1.54 (0.65, 3.65)

2.28* (0.94, 5.53)

1–5 years

cART side effects

Ref

1.07 (0.66, 1.75)

> 5 years

Duration on cART

Ref

–

≤ 1000 copies/mL

Viral load

Body Mass Index

Clinical:

1.13*** (1.09, 1.17)

–
1.04** (1.01, 1.08)

3.83*** (1.85, 7.93)

Perceived HIV-stigma

1.10*** (1.06, 1.13)

2.01** (1.14, 3.53)

–

Low adherence

Ref

–

Ref

2.18*** (1.35, 3.52)

0.94*** (0.93, 0.96)

0.93*** (0.91, 0.96)

Univariate
analysis
OR (95% CI)

High adherence

0.96*** (0.95, 0.98)

0.96*** (0.93, 0.98)

Multivariable
analysis
aOR (95% CI)

Positive screen for GAD symptoms

Medium adherence

Medication adherence

0.94*** (0.92, 0.96)

Health-related
quality of life

Univariate
analysis
OR (95% CI)

Social support

Covariate

Positive screen for depressive
symptoms

Table 5 Univariate and multivariable analysis of correlates of common mental disorders among YLWH from Kenyan coast (Continued)
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The relatively high proportion of depressive symptoms
(12%) among HIV-uninfected peers from our setting
cannot be ignored, especially since previous research
from Kenya also documents a high proportion [56]. Although this work mostly focused on YLWH, from the
analysed data, the death of both parents was a significant
risk indicator for higher depressive symptoms among
community controls. This finding has been previously
observed elsewhere among youths [57]. Higher social
support and health-related quality of life among HIVuninfected young people were the protective indicators
against elevated depressive symptoms. These factors
have also been reported as protective of mental health in
past reviews [58, 59].
In this study, HIV status was found to be an independent predictor of depressive symptoms and its cooccurrence with anxiety symptoms. This finding is consistent with previous research findings from sub-Saharan
Africa [28] but contrasts findings from a study conducted in England by Prevost et al. [21] where HIV status was not associated with depressive or anxiety scores.
The different study setting and studied population could
explain differences in findings. In particular, the control
participants in Prevost et al. [21] study were HIVexposed uninfected youths. These youths may be experiencing similar circumstances as YLWH by virtue of
coming from an HIV affected family, hence the lack of
significant differences in mental health manifestation.
The odd of depressive symptoms among YLWH was
2.5 times higher as the number of negative life events in
the last 1 year increased above 5. This finding is consistent with what has previously been reported in the literature [49, 60]. However, the study design we used
precludes any conclusions on the dose-response relationship for this association. A cohort study among
people living with HIV found no significant difference in
depressive disorder among those with and without an
experience of negative events [61]. Nevertheless, to help
reduce the risk of depression among YLWH, those
reporting considerable recent negative events in life in
this setting should be targeted for early detection and
prompt intervention of any CMD.
Young people 15–24 years old are at the highest risk
of cART attrition compared to younger children and
adults [62]. In this study, close to 9% of YLWH selfreported low adherence to cART, which was significantly
associated with higher odds of anxiety symptoms and its
comorbidity with depressive symptoms. Non-adherence
to HIV treatment may lead to virological nonsuppression due to issues such as drug resistance. Psychological distress can emerge when patients are informed about their poor prognosis. This finding is in
line with previous findings [20, 63] and provides further
evidence of the critical role of addressing medication
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adherence in improving the mental health needs of
YLWH.
Perceived HIV-related stigma was significantly associated with higher odds of depressive symptoms, anxiety
symptoms and their co-occurrence in this study. Other
studies also report similar findings [14, 20, 23]. For a
young person, stigma due to living with HIV may decrease their perceived level of social support in the community, which in turn, may increase mental ill-health
symptoms. Therefore, YLWH experiencing HIV-related
stigma in this or similar settings should be prioritized
for mental health support.
We found that higher social support was a protective indicator against CMDs in YLWH, a finding that is supported by results from other studies [17, 22]. Social
support may relieve psychological distress by improving
self-esteem and decreasing negative cognition [64, 65]. In
the context of living with HIV, higher social support may
give an impression that one is valued and accepted by
others in the society, hence reassurance of self-worth.
Higher health-related quality of life was a protective indicator against CMDs in YLWH. Similarly, Boyes et al. [22]
report that overall perceived better health was protective
against both depressive and anxiety symptoms. In the inverse direction, other studies involving people living with
HIV report significant associations between lower quality
of life and elevated mental health problems [29, 66].
Since both higher social support and health-related
quality of life were also protective indicators against depressive symptoms among HIV-uninfected youths in this
study, community-level programmes seeking to
strengthen the social capital or improve the overall quality of life of these young adults, regardless of HIV status,
have the potential of improving their mental wellbeing.
In this study, sociodemographic and HIV-related clinical factors were not significantly associated with any
CMD among YLWH. Similar observations have been reported within sub-Saharan Africa [19] and elsewhere
[67]. In contrast, other studies from sub-Saharan Africa
have found significant associations between CMDs in
YLWH and demographic or HIV-related clinical factors.
Kim et al. [25] found that primary education or lower
was significantly associated with a 3-fold increase in depressive symptoms compared to high school education
level or higher. Boyes et al. [22] report cART side effects
as a risk factor for both depressive and anxiety symptoms. The presence of opportunistic infections was significantly associated with a near 2-fold increase in
depressive symptoms according to a study by Abebe
et al. [20]. Due to resource constraints in settings such
as Kenya, more research on correlates of CMDs among
YLWH is called for to identify important contextspecific factors for targeted interventions at the Kenyan
coast.
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The strengths of the current study include a focus on
an understudied but rapidly expanding population of
YLWH, use of a comparison group, adequate sample
size, and novel data collection methods. However, there
are limitations too. The cross-sectional study design
limits any causal inference for the reported significant
associations. Our findings may not be generalizable to
younger youths < 18 years. Relatedly, we recruited
YLWH receiving care in public HIV clinics and using
consecutive sampling strategy. These aspects limit the
generalizability of our findings, especially to YLWH who
are out of care or receiving HIV services in private facilities. We used self-report screening tools, which may be
subject to reporting bias. Relatedly, the mental health
screening tools do not give a clinical diagnosis of depression or anxiety. We therefore only report symptomatology of these disorders. Future studies involving YLWH
should also investigate whether the prevalence of CMDs
differ by mode of infection (perinatal versus behavioural)
as this was beyond the scope of the present study.

Implications of the study findings for future research,
clinical care and policy

The study limitations notwithstanding, this work has important implications for future research, policy and care
of young people in early adulthood. We observed a high
prevalence of CMDs particularly among YLWH from
the Kenyan coast and HIV status was predictive of depressive symptoms and its co-occurrence with anxiety
symptoms. There is an urgent need for testing of interventions seeking to address CMDs comorbid with HIV
among youths in this setting. Such interventions,
whether developed or adapted, should be more youthfriendly to increase acceptability.
The high prevalence of CMDs among YLWH at the
Kenyan coast also calls for routine screening of these
mental disorders at the HIV clinics serving these youths.
Routine screening will serve to identify affected young
people early enough and initiate them on an appropriate
support mechanism, including treatment or referral for
specialized care. In so doing, the consequences of CMDs
comorbid with HIV in young people like non-adherence
to cART [68], problems with retention in care [69] and
risky sexual behaviour [70], can be averted.
Compared to anxiety symptoms, the prevalence of depressive symptoms was relatively high among community controls in this study (12%). Such high prevalence
could be driven by factors beyond the data that we collected from community controls and analysed. To appropriately inform policy planners, we recommend a
separate study comprehensively looking at the drivers of
CMDs in the general population of young adults without
HIV.
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Perceived HIV-related stigma and low adherence to
cART significantly increased the risk for CMDs among
YLWH. HIV destigmatization initiatives including multichannel public awareness about the latest advances in
the HIV/AIDS field, and cART adherence support programmes should continue taking centre-stage in this
coastal setting of Kenya, as priority strategies for reducing psychiatric manifestations among these youths.

Conclusion
At the Kenyan Coast, CMDs are more prevalent among
YLWH compared to their uninfected peers. Being HIV
positive as a young person in this setting is predictive of
more depressive symptoms and its comorbidity with
anxiety symptoms. Since early detection and management of mental health problems is key to better health
outcomes, for YLWH in this setting, routine screening
of these CMDs should be integrated in the care package
provided to them at their point of care. Screening should
prioritize YLWH at high risk of CMDs such as those
who have experienced substantial negative life events or
HIV-related stigma in the community, and those with
antiretroviral adherence problems. Continued support to
bereaving HIV-unaffected young adults could help them
come to terms with their loss hence better mental wellbeing. At the community level, programmes strengthening the social capital or improving the overall quality of
life of young adults with or without HIV may be beneficial to their mental health.
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